日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparison with Ezh2 reveals the PRC2-dependent functions of Jarid2 in hematopoietic stem Cell lineage commitment.

与 Ezh2 的比较揭示了 Jarid2 在造血干细胞谱系定向中的 PRC2 依赖性功能。

Bjeije Hassan, Han Wentao, Lin Shuyang, Issa Nancy, Krishnan Aishwarya, Raj Infencia Xavier, Arand Jason, Li Yanan, Yang Wei, Magee Jeffrey A, Challen Grant A

JAK2 (V617F) Myeloproliferative Neoplasms Support Parallel Evolution of Independent Leukemic Clones

JAK2 (V617F) 骨髓增生性肿瘤支持独立白血病克隆的平行进化

Parsons, Tyler M; Krishnan, Aishwarya; Raj, Infencia Xavier; Young, Andrew L; O'Leary, David R; Arand, Jason; Cox, Maggie; Oh, Stephen T; Challen, Grant A

Parallel Evolution of Leukemic Clones in Myeloproliferative Neoplasms.

骨髓增生性肿瘤中白血病克隆的平行演化。

Parsons Tyler M, Krishnan Aishwarya, Raj Infencia Xavier, Young Andrew L, O'Leary David R, Arand Jason, Cox Maggie, Oh Stephen T, Challen Grant A

JARID2 Inhibition Reprograms Human Hematopoietic Progenitor Cells To Enhance Bone Marrow Transplantation.

JARID2抑制剂可重编程人类造血祖细胞以增强骨髓移植

Han Wentao, Bjeije Hassan, Celik Hamza, Rettig Michael, Issa Nancy, Young Andrew L, Li Yanan, Xavier Raj Infencia, Zhang Christine R, Krishnan Aishwarya, Parsons Tyler M, Burkart Samantha C, Arand Jason, Yang Wei, Magee Jeffrey A, Challen Grant A

Functional Comparison to Ezh2 Reveals PRC2-Independent Functions of Jarid2 in Hematopoietic Stem Cell Lineage Commitment.

与 Ezh2 的功能比较揭示了 Jarid2 在造血干细胞谱系定向中的 PRC2 非依赖性功能

Bjeije Hassan, Han Wentao, Issa Nancy, Krishnan Aishwarya, Raj Infencia Xavier, Arand Jason, Li Yanan, Yang Wei, Magee Jeffrey A, Challen Grant A

Engineering a humanized animal model of polycythemia vera with minimal JAK2V617F mutant allelic burden

构建JAK2V617F突变等位基因负荷最小的人源化真性红细胞增多症动物模型

Parsons, Tyler M; Krishnan, Aishwarya; Dunuwille, Wangisa M B; Young, Andrew L; Arand, Jason; Han, Wentao; Challen, Grant A

Venous Thromboembolism (VTE) in May-Thurner Syndrome: Decision-Making Related to Long-Term Anticoagulation

May-Thurner综合征中的静脉血栓栓塞症(VTE):与长期抗凝治疗相关的决策

Krishnan, Aishwarya; Desai, Purav

Targetable treatment resistance in thyroid cancer with clonal hematopoiesis

伴有克隆性造血的甲状腺癌的靶向治疗耐药性

Tiedje, Vera; Vela, Pablo Sánchez; Yang, Julie L; Untch, Brian R; Boucai, Laura; Stonestrom, Aaron J; Costa, Alberto Bueno; Expósito, Sebastià Franch; Srivastava, Avi; Kerpelev, Marina; Greenberg, Jillian; Wereski, Mathew; Kulick, Amanda; Chen, Kevin; Qin, Tianyue; Im, Soo-Yeon; Krishnan, Aishwarya; Martinez Benitez, Anthony R; Pluvinet, Raquel; Sahin, Merve; Menghrajani, Kamal; Krishnamoorthy, Gnana P; de Stanchina, Elisa; Zehir, Ahmet; Satija, Rahul; Knauf, Jeffrey; Bowman, Robert L; Esteller, Manel; Devlin, Sean; Berger, Michael F; Koche, Richard P; Fagin, James A; Levine, Ross L

BIRC5 upregulation enhances DNMT3A-mutant T-ALL cell survival and pathogenesis

BIRC5 上调增强 DNMT3A 突变型 T 细胞急性淋巴细胞白血病 (T-ALL) 细胞的存活和致病性

Dunuwille, Wangisa; Wilson, William C; Bjeije, Hassan; Issa, Nancy; Han, Wentao; Parsons, Tyler M; Young, Andrew L; Xavier Raj, Infencia; Krishnan, Aishwarya; Gaur, Tarang; Wang, Eunice S; Weng, Andrew P; Stubbs, Matthew C; Celik, Hamza; Cashen, Amanda F; Edwards, John R; Challen, Grant A

CXCL8/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosis

CXCL8/CXCR2信号通路介导骨髓纤维化,是骨髓纤维化的治疗靶点。

Dunbar, Andrew J; Kim, Dongjoo; Lu, Min; Farina, Mirko; Bowman, Robert L; Yang, Julie L; Park, Young; Karzai, Abdul; Xiao, Wenbin; Zaroogian, Zach; O'Connor, Kavi; Mowla, Shoron; Gobbo, Francesca; Verachi, Paola; Martelli, Fabrizio; Sarli, Giuseppe; Xia, Lijuan; Elmansy, Nada; Kleppe, Maria; Chen, Zhuo; Xiao, Yang; McGovern, Erin; Snyder, Jenna; Krishnan, Aishwarya; Hill, Corrine; Cordner, Keith; Zouak, Anouar; Salama, Mohamed E; Yohai, Jayden; Tucker, Eric; Chen, Jonathan; Zhou, Jing; McConnell, Timothy; Migliaccio, Anna R; Koche, Richard; Rampal, Raajit; Fan, Rong; Levine, Ross L; Hoffman, Ronald